[go: up one dir, main page]

GB9822712D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB9822712D0
GB9822712D0 GBGB9822712.7A GB9822712A GB9822712D0 GB 9822712 D0 GB9822712 D0 GB 9822712D0 GB 9822712 A GB9822712 A GB 9822712A GB 9822712 D0 GB9822712 D0 GB 9822712D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9822712.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9822712.7A priority Critical patent/GB9822712D0/en
Publication of GB9822712D0 publication Critical patent/GB9822712D0/en
Priority to EP10176856A priority patent/EP2266604A3/en
Priority to EP07100777A priority patent/EP1797896A1/en
Priority to PT99970607T priority patent/PT1126876E/en
Priority to AT99970607T priority patent/ATE357252T1/en
Priority to JP2000576878A priority patent/JP2003519084A/en
Priority to AU11518/00A priority patent/AU750587B2/en
Priority to CZ20011341A priority patent/CZ301212B6/en
Priority to DE69935606.7T priority patent/DE69935606T9/en
Priority to CNB2004100694428A priority patent/CN100406060C/en
Priority to CN2009101731658A priority patent/CN101926993B/en
Priority to CNB998143413A priority patent/CN100558401C/en
Priority to NZ511113A priority patent/NZ511113A/en
Priority to HU0203091A priority patent/HU228473B1/en
Priority to BRPI9915545A priority patent/BRPI9915545B8/en
Priority to PL348121A priority patent/PL201482B1/en
Priority to CA2773698A priority patent/CA2773698C/en
Priority to DE122007000087C priority patent/DE122007000087I1/en
Priority to DK99970607T priority patent/DK1126876T3/en
Priority to US09/807,657 priority patent/US7357936B1/en
Priority to CA2347099A priority patent/CA2347099C/en
Priority to EP99970607A priority patent/EP1126876B1/en
Priority to ES99970607T priority patent/ES2284287T3/en
Priority to TR2001/01055T priority patent/TR200101055T2/en
Priority to EP05077501A priority patent/EP1666060A1/en
Priority to EP05076368A priority patent/EP1588714A2/en
Priority to IL14239599A priority patent/IL142395A0/en
Priority to PCT/EP1999/007764 priority patent/WO2000023105A2/en
Priority to SI9930966T priority patent/SI1126876T1/en
Priority to KR1020017004793A priority patent/KR100629028B1/en
Priority to MYPI99004448A priority patent/MY124689A/en
Priority to TW088117873A priority patent/TW586936B/en
Priority to ARP990105237A priority patent/AR020836A1/en
Priority to CO99065652A priority patent/CO5210894A1/en
Priority to IL142395A priority patent/IL142395A/en
Priority to NO20011801A priority patent/NO336250B1/en
Priority to HK02100151.3A priority patent/HK1038695B/en
Priority to CY20071100661T priority patent/CY1106596T1/en
Priority to JP2007187001A priority patent/JP5563189B2/en
Priority to CY200700032C priority patent/CY2007032I2/en
Priority to FR07C0064C priority patent/FR07C0064I1/en
Priority to LU91389C priority patent/LU91389I2/en
Priority to NL300311C priority patent/NL300311I2/en
Priority to US11/945,493 priority patent/US8628784B2/en
Priority to JP2012051129A priority patent/JP5667107B2/en
Priority to HUS1300050C priority patent/HUS1300050I1/en
Priority to US14/134,388 priority patent/US9623114B2/en
Ceased legal-status Critical Current

Links

GBGB9822712.7A 1998-10-16 1998-10-16 Vaccine Ceased GB9822712D0 (en)

Priority Applications (47)

Application Number Priority Date Filing Date Title
GBGB9822712.7A GB9822712D0 (en) 1998-10-16 1998-10-16 Vaccine
EP10176856A EP2266604A3 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
EP07100777A EP1797896A1 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
PT99970607T PT1126876E (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
AT99970607T ATE357252T1 (en) 1998-10-16 1999-10-08 ADJUVANCE SYSTEMS AND VACCINES
JP2000576878A JP2003519084A (en) 1998-10-16 1999-10-08 vaccine
AU11518/00A AU750587B2 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
CZ20011341A CZ301212B6 (en) 1998-10-16 1999-10-08 Vaccine composition
DE69935606.7T DE69935606T9 (en) 1998-10-16 1999-10-08 ADJUVANCE SYSTEMS AND VACCINE
CNB2004100694428A CN100406060C (en) 1998-10-16 1999-10-08 Adjuvant composition
CN2009101731658A CN101926993B (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
CNB998143413A CN100558401C (en) 1998-10-16 1999-10-08 Adjuvant system and vaccine
NZ511113A NZ511113A (en) 1998-10-16 1999-10-08 Adjuvant systems containing an immunostimulant absorbed on to a metal salt particle and vaccines thereof
HU0203091A HU228473B1 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
BRPI9915545A BRPI9915545B8 (en) 1998-10-16 1999-10-08 vaccine composition, process for preparing the same and kit comprising two containers.
PL348121A PL201482B1 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
CA2773698A CA2773698C (en) 1998-10-16 1999-10-08 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
DE122007000087C DE122007000087I1 (en) 1998-10-16 1999-10-08 ADJUVANCY SYSTEMS AND VACCINES
DK99970607T DK1126876T3 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
US09/807,657 US7357936B1 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
CA2347099A CA2347099C (en) 1998-10-16 1999-10-08 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
EP99970607A EP1126876B1 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
ES99970607T ES2284287T3 (en) 1998-10-16 1999-10-08 ADJUSTMENT SYSTEMS AND VACCINES.
TR2001/01055T TR200101055T2 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
EP05077501A EP1666060A1 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
EP05076368A EP1588714A2 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
IL14239599A IL142395A0 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
PCT/EP1999/007764 WO2000023105A2 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
SI9930966T SI1126876T1 (en) 1998-10-16 1999-10-08 Adjuvant systems and vaccines
KR1020017004793A KR100629028B1 (en) 1998-10-16 1999-10-08 Adjuvant Systems and Vaccines
MYPI99004448A MY124689A (en) 1998-10-16 1999-10-14 Adjuvant systems and vaccines
TW088117873A TW586936B (en) 1998-10-16 1999-10-15 Adjuvant composition, vaccine composition, process for manufacture thereof and kit comprising same
ARP990105237A AR020836A1 (en) 1998-10-16 1999-10-15 VACCINES
CO99065652A CO5210894A1 (en) 1998-10-16 1999-10-15 ASSISTANT COMPOSITIONS THAT INCLUDE AN ALUMINUM SALT AND AN IMMUNO STIMULANT
IL142395A IL142395A (en) 1998-10-16 2001-04-03 Adjuvant systems and vaccines
NO20011801A NO336250B1 (en) 1998-10-16 2001-04-09 Vaccine compositions and methods for preparing them
HK02100151.3A HK1038695B (en) 1998-10-16 2002-01-09 Adjuvant systems and vaccines
CY20071100661T CY1106596T1 (en) 1998-10-16 2007-05-16 ADHESIVE SYSTEMS AND VACCINES
JP2007187001A JP5563189B2 (en) 1998-10-16 2007-07-18 vaccine
CY200700032C CY2007032I2 (en) 1998-10-16 2007-11-26 ADHESIVE SYSTEMS AND VACCINES
FR07C0064C FR07C0064I1 (en) 1998-10-16 2007-12-14 ADDITIONAL PRODUCTS AND VACCINES
LU91389C LU91389I2 (en) 1998-10-16 2007-12-14 "HPV16 and HPV18L1 particle combination" CERVARIX
NL300311C NL300311I2 (en) 1998-10-16 2007-12-14 Adjuvant systems and vaccines
US11/945,493 US8628784B2 (en) 1998-10-16 2008-02-28 Adjuvant systems and vaccines
JP2012051129A JP5667107B2 (en) 1998-10-16 2012-03-08 vaccine
HUS1300050C HUS1300050I1 (en) 1998-10-16 2013-09-09 Adjuvant systems and vaccines
US14/134,388 US9623114B2 (en) 1998-10-16 2013-12-19 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822712.7A GB9822712D0 (en) 1998-10-16 1998-10-16 Vaccine

Publications (1)

Publication Number Publication Date
GB9822712D0 true GB9822712D0 (en) 1998-12-09

Family

ID=10840770

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9822712.7A Ceased GB9822712D0 (en) 1998-10-16 1998-10-16 Vaccine

Country Status (1)

Country Link
GB (1) GB9822712D0 (en)

Similar Documents

Publication Publication Date Title
IL140094A0 (en) Vaccine
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
PL341761A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
GB9806456D0 (en) Vaccine composition
HUP0105392A3 (en) Enhanced vaccines
GB9822714D0 (en) Vaccines
IL139467A0 (en) Vaccine
GB9801870D0 (en) Vaccine composition
GB9820956D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9807805D0 (en) Vaccine
GB9811954D0 (en) Vaccine
GB9822703D0 (en) Vaccine
GB9822712D0 (en) Vaccine
GB9807933D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9806765D0 (en) Vaccine
GB9812773D0 (en) Vaccine
GB9805962D0 (en) Vaccine
GB9822709D0 (en) Vaccine
GB9805961D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)